IN HB1345 | 2018 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on January 16 2018 - 25% progression, died in committee
Action: 2018-01-18 - Representative Brown, C. added as coauthor
Pending: House Public Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Prescription drug pricing study. Urges the legislative council to assign to the interim study committee on public health, behavioral health, and human services the task of studying issues related to prescription drug price transparency by drug manufacturers in Indiana.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prescription drug pricing study. Urges the legislative council to assign to the interim study committee on public health, behavioral health, and human services the task of studying issues related to prescription drug price transparency by drug manufacturers in Indiana.

Sponsors


History

DateChamberAction
2018-01-18HouseRepresentative Brown, C. added as coauthor
2018-01-16HouseFirst reading: referred to Committee on Public Health
2018-01-16HouseAuthored by Representative Shackleford

Indiana State Sources


Bill Comments

feedback